Lower-middle income (World Bank) vs Tonga: Smear-positive tuberculosis treatment-success rate
Lower-middle income (World Bank)
88.0%
in 2011
Tonga
100.0%
in 2011
Lower-middle income (World Bank) rank
3rd
Tonga rank
1st
Smear-positive tuberculosis treatment-success rate over time
- Lower-middle income (World Bank)
- Tonga
How they compare
Tonga currently reports 100.0% against 88.0% in Lower-middle income (World Bank), a difference of 12.0%.
That makes Tonga's figure about 1.1 times Lower-middle income (World Bank)'s.
The two have swapped places 4 times across 16 shared years of data; in 1994 it was Tonga ahead.
Lower-middle income (World Bank) ranks 3rd and Tonga ranks 1st of 10 groups.
Tonga has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Lower-middle income (World Bank) | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 48.0% | 82.5% | 34.5% | Tonga |
| 2000s | 78.2% | 89.6% | 11.4% | Tonga |
| 2010s | 88.0% | 91.5% | 3.5% | Tonga |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher smear-positive tuberculosis treatment-success rate, Lower-middle income (World Bank) or Tonga?
- Tonga, at 100.0% against 88.0% in Lower-middle income (World Bank) as of 2011.
- What is the difference in smear-positive tuberculosis treatment-success rate between Lower-middle income (World Bank) and Tonga?
- 12.0%, with Tonga ahead.
- How many years of comparable data are there for Lower-middle income (World Bank) and Tonga?
- 16 years are reported by both, from 1994 to 2011.
- How do Lower-middle income (World Bank) and Tonga rank globally for smear-positive tuberculosis treatment-success rate?
- Lower-middle income (World Bank) ranks 3rd and Tonga ranks 1st of 10 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Smear-positive tuberculosis treatment-success rate (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.